Clinical Trial Update: Surgical Treatment With or Without Apalutamide in Subjects With High Risk Prostate Cancer Who Are Candidates for Radical Prostatectomy and Staged as Oligometastatic With PSMA-PET [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating surgical treatment with or without apalutamide in men with high-risk, oligometastatic prostate cancer staged with PSMA-PET. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Apalutamide (apalutamide)

Snippet

Sponsor: Marco Oderda | Conditions: High Risk Prostate Cancer | Phase 2 | Status: RECRUITING